We are live on ! Find out more
VU

Valence8 US Portfolio holdings

AUM $300M
1-Year Est. Return 27.26%
This Fund
S&P 500
This Quarter Est. Return
+15.05%
1 Year Est. Return
+27.26%
3 Year Est. Return
+69.88%
5 Year Est. Return
10 Year Est. Return
AUM
$300M
AUM Growth
+$14.4M
Cap. Flow
-$25.4M
Cap. Flow %
-8.46%
Top 10 Hldgs %
92.55%
Holding
15
New
1
Increased
6
Reduced
6
Closed

No holdings matched the selected filter criteria.

Similar funds

Valence8 US's Q2 2026 Portfolio in Review

As of Q2 2026, Valence8 US held 15 positions worth $300M, up 5% from $286M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Valence8 US withdrew a net $25.4M in Q2 2026, reducing 6 holdings. Its largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $32.1M.

Against the trend, Valence8 US opened a new position in State Street Health Care Select Sector SPDR ETF worth $14.8M.

  • Valence8 US's largest Q2 2026 buy was State Street Health Care Select Sector SPDR ETF: 93,378 shares worth $14.8M.
  • Valence8 US added most to iShares MSCI USA Quality Factor ETF in Q2 2026, an estimated $15.7M increase.
  • Valence8 US's biggest Q2 2026 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $32.1M.
  • Valence8 US's ten largest holdings make up 93% of its $300M portfolio in Q2 2026.
  • Valence8 US opened 1 new position and closed 0 in Q2 2026.
  • Valence8 US's portfolio value rose 5% quarter-over-quarter to $300M.

Based on Valence8 US's 13F filing for Q2 2026, filed 6 Aug 2026.